Inspira Technologies Oxy B.H.N. Ltd (IINN)
| Market Cap | 78.56M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | 8.79M |
| Shares Out | 13.09M |
| EPS (ttm) | 0.67 |
| PE Ratio | 8.94 |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | n/a |
| Last Price | n/a |
| Previous Close | n/a |
| Change ($) | n/a |
| Change (%) | n/a |
| Day's Open | n/a |
| Day's Range | n/a |
| Day's Volume | n/a |
| 52-Week Range | n/a |
Inspira Technologies OXY, which is developing minimally invasive devices for mechanical ventilation, filed on Friday with the SEC to raise up to $18 million in an initial public offering.
Inspira Technologies Oxy B.H.N. Ltd has filed to go public with an IPO on the NASDAQ.
About IINN
Inspira Technologies Oxy is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation, or MV, which is the standard of care today for the treatment of respiratory failure. Our lead product, the augmented respiration technology system, or ART system, is a novel respiratory support system, comprised of a minimally invasive, portable dual lumen cannula which is inserted into the jugul... [Read more...]
| Industry Surgical & Medical Instruments & Apparatus | IPO Date Pending |
| CEO Dagi Ben-Noon | Employees 24 |
| Stock Exchange NASDAQ | Ticker Symbol IINN |